2019
An Automated Text Message Navigation Program Improves the Show Rate for Outpatient Colonoscopy
Mahmud N, Doshi SD, Coniglio MS, Clermont M, Bernard D, Reitz C, Khungar V, Asch DA, Mehta SJ. An Automated Text Message Navigation Program Improves the Show Rate for Outpatient Colonoscopy. Health Education & Behavior 2019, 46: 942-946. PMID: 31431077, PMCID: PMC6889043, DOI: 10.1177/1090198119869964.Peer-Reviewed Original ResearchConceptsIntervention patientsNavigation programAppointment adherenceColonoscopy completionOutpatient colonoscopyPreparation qualityUsual care armPoor bowel preparationBowel preparation qualityHigh patient satisfactionCare armUsual careIntervention armBowel preparationProspective studyAdherence ratesColonoscopy adherencePatient satisfactionEndoscopy centerSimilar demographicsProcedure cancellationsShow ratesPatientsPoststudy surveyAdherence
2017
Safety and efficacy of current direct‐acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV‐TARGET study
Saxena V, Khungar V, Verna EC, Levitsky J, Brown RS, Hassan MA, Sulkowski MS, O'Leary JG, Koraishy F, Galati JS, Kuo AA, Vainorius M, Akushevich L, Nelson DR, Fried MW, Terrault N, Reddy KR. Safety and efficacy of current direct‐acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV‐TARGET study. Hepatology 2017, 66: 1090-1101. PMID: 28504842, PMCID: PMC5756478, DOI: 10.1002/hep.29258.Peer-Reviewed Original ResearchConceptsSustained virologic responseOmbitasvir/paritaprevir/ritonavirParitaprevir/ritonavirTransplant recipientsLiver transplantKidney transplantAntiviral therapyLarge prospective observational cohort studyChronic hepatitis C virusLiver-kidney transplant recipientsProspective observational cohort studySolid organ transplant recipientsHepatitis C virus (HCV) treatmentBaseline total bilirubinHCV-TARGET studyPrior antiviral therapyAbsence of cirrhosisKidney transplant recipientsLiver transplant recipientsObservational cohort studyOrgan transplant recipientsC virus treatmentGlomerular filtration rateCessation of treatmentSOF/ledipasvir